|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/40 | |
| A61P 9/06 |
| (11) | Number of the document | 1868598 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05826333.6 |
| Date of filing the European patent application | 2005-11-08 | |
| (97) | Date of publication of the European application | 2007-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2014-04-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/040585 |
| Date | 2005-11-08 |
| (87) | Number | WO 2006/053037 |
| Date | 2006-05-18 |
| (30) | Number | Date | Country code |
| 626328 P | 2004-11-08 | US | |
| 652185 P | 2005-02-10 | US | |
| 676463 P | 2005-04-29 | US | |
| 702873 P | 2005-07-27 | US | |
| 729387 P | 2005-10-21 | US |
| (72) |
BEATCH, Gregory, N., CA
CLOHS, Lilian, CA
|
| (73) |
Cardiome Pharma Corp.,
6190 Agronomy Road 6th Floor, Vancouver, B.C. V6T 1Z3,
CA
|
| (54) | A NEW DOSING REGIMEN FOR ION CHANNEL MODULATING COMPOUNDS FOR TREATING ACUTE ATRIAL FIBRILLATION IN A HUMAN |
| A NEW DOSING REGIMEN FOR ION CHANNEL MODULATING COMPOUNDS FOR TREATING ACUTE ATRIAL FIBRILLATION IN A HUMAN |